Atlas Trials

Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)

Clinical trial NCT00246909 · COMPLETED

Trial details

NCT number
NCT00246909
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Gastroesophageal Reflux
Start date
2005-11-01
Primary completion
2006-11-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.